Region: Belgium

Belgian practitioner swaps A&O for Crowell

Werner Eyskens, who advises on construction and post-M&A arbitrations and was part of the largest-ever case heard by Belgian institution CEPANI, has left the partnership at Allen & Overy to join Crowell & Moring in Brussels.

28 June 2022

Janssen faces fresh claim over cancer drug royalties

A Danish biotech company has renewed its dispute with Belgium’s Janssen Pharmaceuticals, claiming US$405 million over a blood cancer treatment just weeks after a tribunal dismissed an earlier arbitration concerning the same licensing agreement.

10 June 2022

Janssen secures win in cancer drug royalties dispute

Belgian pharmaceuticals company Janssen has defeated a claim brought by a Danish biotech company over royalties due for a blood cancer treatment.

08 April 2022

Poland overturns denial of justice award

A Brussels court has set aside a US$10 million UNCITRAL award that held Poland liable for a denial of justice – in what is thought to be the first time an investment treaty award has been annulled in Belgium.

01 March 2022

Edison loses award challenge in environmental dispute

A Swiss court has upheld an ICC award requiring Italian power utility Edison to pay over €91 million to Belgian chemicals producer Solvay for breaches of environmental guarantees relating to the sale of two industrial plants two decades ago.

16 February 2022

Belgian supreme court to rule on tribunal secretaries

Belgium’s Court of Cassation has been asked to review a court ruling that found the drafting of an ICC award by a secretary was not an improper delegation of the tribunal’s decision-making powers.

02 February 2022

Belgian court finds Stati award obtained by fraud

A Belgian court has ruled that a US$545 million Energy Charter Treaty award against Kazakhstan cannot be enforced, finding that Moldovan creditors Anatolie and Gabriel Stati obtained it through fraud.

17 November 2021

Belgian-Brazilian hygiene M&A dispute settles

A Belgium-based provider of personal hygiene products has agreed to settle an ICC claim against a Brazilian pharmaceuticals group over a €300 million acquisition.

17 September 2021

Rwanda threatened over seizure of gold refinery

A Belgian business magnate has threatened Rwanda with a US$50 million ICSID claim, alleging his refinery was subject to a “hostile take-over” and the seizure of gold bars by state authorities.

09 September 2021

Belgian centre rules on multibillion pharma fraud claim

A US pharmaceutical company says it has prevailed in what is thought to be the largest-ever case heard at Belgian arbitral institution CEPANI, concerning alleged fraud during a US$4.3 billion acquisition.

03 September 2021

Unlock unlimited access to all Global Arbitration Review content